Skip to main content
Bain Capital's life sciences fund gets $720M boost

Private equity firm Bain Capital has closed its first life sciences investment fund, named Bain Capital Life Sciences, at $720 million. The fund aims to invest $30 million to $70 million in private and public companies in the areas of medical devices, biotech and specialty pharmaceuticals and will take part in leveraged buyouts in collaboration with Bain Capital's private equity funds.

Full Story: